Global Injectable Drug Delivery Market Research and Analysis, 2015-2021
MARKET INSIGHTS
Global injectable drug delivery market is expected to grow at a CAGR of 10% for the forecasted period of 2016-2021. Some of the top selling drugs are delivered using injections and implants. Drugs delivered using injections are considered to act more effectively and for longer duration compared to the orally administered drugs. The market for injectable drug delivery is segmented on the basis of mode of administration, by usability, by type and by therapeutic applications. The injectable drug delivery market is delivered by various factors. One of the major factors driving the market is rising prevalence and incidence of chronic diseases such as diabetes, hormonal disorder, reproductive health issue and other major diseases. The market is also driven technological advancement, innovations and ongoing R&Ds. The growth of self-injections is very high. The market is overtaking the conventional drug delivery market. It is also driving the market to grow.
Regionally, North America has the highest market share. The market is driven by high awareness, availability of reimbursement, high use of self-injectors and other major factors are driving the North American market. Europe is the second largest market segment. Asia Pacific is the fastest growing market. It is driven by high population suffering from chronic diseases and improving healthcare system.
Global injectable drug delivery market is expected to grow at a CAGR of 10% for the forecasted period of 2016-2021. Some of the top selling drugs are delivered using injections and implants. Drugs delivered using injections are considered to act more effectively and for longer duration compared to the orally administered drugs. The market for injectable drug delivery is segmented on the basis of mode of administration, by usability, by type and by therapeutic applications. The injectable drug delivery market is delivered by various factors. One of the major factors driving the market is rising prevalence and incidence of chronic diseases such as diabetes, hormonal disorder, reproductive health issue and other major diseases. The market is also driven technological advancement, innovations and ongoing R&Ds. The growth of self-injections is very high. The market is overtaking the conventional drug delivery market. It is also driving the market to grow.
Regionally, North America has the highest market share. The market is driven by high awareness, availability of reimbursement, high use of self-injectors and other major factors are driving the North American market. Europe is the second largest market segment. Asia Pacific is the fastest growing market. It is driven by high population suffering from chronic diseases and improving healthcare system.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUG AND DEVICES REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH MARKET GROWTH OF SELF-INJECTORS
3.1.2. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.1.3. GROWING PREVALENCE AND INCIDENCE OF CHRONIC DISEASES
3.1.4. HIGH DEMAND AMONGST DIABETIC PATIENTS
3.2. RESTRAINT
3.2.1. STRICT GOVERNMENT REGULATIONS
3.2.2. SAFETY AND STERILITY OF PRODUCTS
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. TECHNOLOGY ADVANCEMENTS
DRUG DELIVERY-@PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL INJECTABLE DRUG DELIVERY BY MODE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.1. GLOBAL ORAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.2. GLOBAL PULMONARY INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.3. GLOBAL TRANSDERMAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.4. GLOBAL NASAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.5. GLOBAL IMPLANTABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.6. GLOBAL OTHER INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2. GLOBAL INJECTABLE DRUG DELIVERY BY USABILITY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1. GLOBAL REUSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.1. GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.2. GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.3. GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.4. GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2. GLOBAL DISPOSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.1. GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.2. GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.3. GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.4. GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3. GLOBAL INJECTABLE DRUG DELIVERY BY TYPE MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1. GLOBAL PHARMACEUTICAL DRUG FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1. GLOBAL FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1. GLOBAL CONVENTIONAL DRUGS DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.1. GLOBAL SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.2. GLOBAL RECONSTITUTED FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.3. GLOBAL SUSPENSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.4. GLOBAL EMULSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2. GLOBAL ADVANCED DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1. GLOBAL COLLOIDAL DISPERSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.1. GLOBAL LIPOSOMES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.2. GLOBAL NANOPARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.3. GLOBAL NOISOMES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.4. GLOBAL MICRO PARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.5. GLOBAL POLYMERIC MICELLES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.3. GLOBAL OTHER FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2. GLOBAL INJECTABLE DRUG DELIVERY BY DEVICES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.1. GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.1.1. GLOBAL FILLABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.1.2. GLOBAL PRE FILLED INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2. GLOBAL SELF-INJECTION DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.1. GLOBAL NEEDLE-FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.1.1. GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.1.2. GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.2. GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.2.1. GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.2.2. GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.3. GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4. GLOBAL ANAEMIA MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.1. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.2. GLOBAL HORMONAL INJECTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.3. GLOBAL RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.4. GLOBAL CROHN’S DISEASES MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.5. GLOBAL MULTIPLE SCLEROSIS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.6. GLOBAL PSORIASIS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.7. GLOBAL REPRODUCTIVE HEALTH MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.8. GLOBAL ALLERGY MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.9. GLOBAL OTHER THERAPEUTIC APPLICATION MARKET RESEARCH AND ANALYSIS 2015-2021
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
8.1. ALKERMES PLC
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2. ANTARES PHARMA
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. BECTON DICKINSON AND COMPANY
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. BIOPHARMA SOLUTIONS (BAXTER INTERNATIONAL INC.)
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. ELI LILLY AND COMPANY
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. GENENTECH INC.
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. GERRESHEIMER AG
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. GLAXOSMITHKLINE INC.
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. HIKMA PHARMACEUTICALS PLC
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. LIFELONG MEDITECH LTD.
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. NOVARTIS
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. PFIZER INJECTABLES (PFIZER INC.)
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. SANDOZ
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. SCHOTT AG
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. SHL GROUP
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.15.4. SWOT
8.16. TERUMO CORPORATION
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. TEVA PHARMACEUTICAL INDUSTRIES LTD
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. TROIKAA PHARMACEUTICALS LTD.
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. WEIGAO GROUP
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. YPSOMED
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. TAX LAWS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
2.6.2. DRUG AND DEVICES REGULATIONS
2.6.2.1. UNITED STATES
2.6.2.2. EUROPEAN UNION
2.6.2.3. CHINA
2.6.2.4. INDIA
2.6.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. HIGH MARKET GROWTH OF SELF-INJECTORS
3.1.2. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
3.1.3. GROWING PREVALENCE AND INCIDENCE OF CHRONIC DISEASES
3.1.4. HIGH DEMAND AMONGST DIABETIC PATIENTS
3.2. RESTRAINT
3.2.1. STRICT GOVERNMENT REGULATIONS
3.2.2. SAFETY AND STERILITY OF PRODUCTS
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. TECHNOLOGY ADVANCEMENTS
DRUG DELIVERY-@PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL INJECTABLE DRUG DELIVERY BY MODE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.1. GLOBAL ORAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.2. GLOBAL PULMONARY INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.3. GLOBAL TRANSDERMAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.4. GLOBAL NASAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.5. GLOBAL IMPLANTABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.1.6. GLOBAL OTHER INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2. GLOBAL INJECTABLE DRUG DELIVERY BY USABILITY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1. GLOBAL REUSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.1. GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.2. GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.3. GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.1.4. GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2. GLOBAL DISPOSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.1. GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.2. GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.3. GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.2.2.4. GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3. GLOBAL INJECTABLE DRUG DELIVERY BY TYPE MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1. GLOBAL PHARMACEUTICAL DRUG FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1. GLOBAL FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1. GLOBAL CONVENTIONAL DRUGS DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.1. GLOBAL SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.2. GLOBAL RECONSTITUTED FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.3. GLOBAL SUSPENSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.1.4. GLOBAL EMULSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2. GLOBAL ADVANCED DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1. GLOBAL COLLOIDAL DISPERSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.1. GLOBAL LIPOSOMES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.2. GLOBAL NANOPARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.3. GLOBAL NOISOMES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.4. GLOBAL MICRO PARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.2.1.5. GLOBAL POLYMERIC MICELLES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.1.1.3. GLOBAL OTHER FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2. GLOBAL INJECTABLE DRUG DELIVERY BY DEVICES MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.1. GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.1.1. GLOBAL FILLABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.1.2. GLOBAL PRE FILLED INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2. GLOBAL SELF-INJECTION DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.1. GLOBAL NEEDLE-FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.1.1. GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.1.2. GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.2. GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.2.1. GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.2.2. GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
5.3.2.2.3. GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4. GLOBAL ANAEMIA MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.1. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.2. GLOBAL HORMONAL INJECTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.3. GLOBAL RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.4. GLOBAL CROHN’S DISEASES MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.5. GLOBAL MULTIPLE SCLEROSIS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.6. GLOBAL PSORIASIS MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.7. GLOBAL REPRODUCTIVE HEALTH MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.8. GLOBAL ALLERGY MARKET RESEARCH AND ANALYSIS 2015-2021
5.4.9. GLOBAL OTHER THERAPEUTIC APPLICATION MARKET RESEARCH AND ANALYSIS 2015-2021
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
8.1. ALKERMES PLC
8.1.1. INTRODUCTION
8.1.2. PRODUCT PORTFOLIO
8.1.3. RECENT ACTIVITIES
8.1.4. SWOT
8.2. ANTARES PHARMA
8.2.1. INTRODUCTION
8.2.2. PRODUCT PORTFOLIO
8.2.3. RECENT ACTIVITIES
8.2.4. SWOT
8.3. BECTON DICKINSON AND COMPANY
8.3.1. INTRODUCTION
8.3.2. PRODUCT PORTFOLIO
8.3.3. RECENT ACTIVITIES
8.3.4. SWOT
8.4. BIOPHARMA SOLUTIONS (BAXTER INTERNATIONAL INC.)
8.4.1. INTRODUCTION
8.4.2. PRODUCT PORTFOLIO
8.4.3. RECENT ACTIVITIES
8.4.4. SWOT
8.5. ELI LILLY AND COMPANY
8.5.1. INTRODUCTION
8.5.2. PRODUCT PORTFOLIO
8.5.3. RECENT ACTIVITIES
8.5.4. SWOT
8.6. GENENTECH INC.
8.6.1. INTRODUCTION
8.6.2. PRODUCT PORTFOLIO
8.6.3. RECENT ACTIVITIES
8.6.4. SWOT
8.7. GERRESHEIMER AG
8.7.1. INTRODUCTION
8.7.2. PRODUCT PORTFOLIO
8.7.3. RECENT ACTIVITIES
8.7.4. SWOT
8.8. GLAXOSMITHKLINE INC.
8.8.1. INTRODUCTION
8.8.2. PRODUCT PORTFOLIO
8.8.3. RECENT ACTIVITIES
8.8.4. SWOT
8.9. HIKMA PHARMACEUTICALS PLC
8.9.1. INTRODUCTION
8.9.2. PRODUCT PORTFOLIO
8.9.3. RECENT ACTIVITIES
8.9.4. SWOT
8.10. LIFELONG MEDITECH LTD.
8.10.1. INTRODUCTION
8.10.2. PRODUCT PORTFOLIO
8.10.3. RECENT ACTIVITIES
8.10.4. SWOT
8.11. NOVARTIS
8.11.1. INTRODUCTION
8.11.2. PRODUCT PORTFOLIO
8.11.3. RECENT ACTIVITIES
8.11.4. SWOT
8.12. PFIZER INJECTABLES (PFIZER INC.)
8.12.1. INTRODUCTION
8.12.2. PRODUCT PORTFOLIO
8.12.3. RECENT ACTIVITIES
8.12.4. SWOT
8.13. SANDOZ
8.13.1. INTRODUCTION
8.13.2. PRODUCT PORTFOLIO
8.13.3. RECENT ACTIVITIES
8.13.4. SWOT
8.14. SCHOTT AG
8.14.1. INTRODUCTION
8.14.2. PRODUCT PORTFOLIO
8.14.3. RECENT ACTIVITIES
8.14.4. SWOT
8.15. SHL GROUP
8.15.1. INTRODUCTION
8.15.2. PRODUCT PORTFOLIO
8.15.3. RECENT ACTIVITIES
8.15.4. SWOT
8.16. TERUMO CORPORATION
8.16.1. INTRODUCTION
8.16.2. PRODUCT PORTFOLIO
8.16.3. RECENT ACTIVITIES
8.16.4. SWOT
8.17. TEVA PHARMACEUTICAL INDUSTRIES LTD
8.17.1. INTRODUCTION
8.17.2. PRODUCT PORTFOLIO
8.17.3. RECENT ACTIVITIES
8.17.4. SWOT
8.18. TROIKAA PHARMACEUTICALS LTD.
8.18.1. INTRODUCTION
8.18.2. PRODUCT PORTFOLIO
8.18.3. RECENT ACTIVITIES
8.18.4. SWOT
8.19. WEIGAO GROUP
8.19.1. INTRODUCTION
8.19.2. PRODUCT PORTFOLIO
8.19.3. RECENT ACTIVITIES
8.19.4. SWOT
8.20. YPSOMED
8.20.1. INTRODUCTION
8.20.2. PRODUCT PORTFOLIO
8.20.3. RECENT ACTIVITIES
8.20.4. SWOT
LIST OF TABLES
TABLE # 1 GLOBAL INJECTABLE DRUG DELIVERY BY MODE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 2 GLOBAL ORAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 3 GLOBAL PULMONARY INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 4 GLOBAL TRANSDERMAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 5 GLOBAL NASAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 6 GLOBAL IMPLANTABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 7 GLOBAL OTHER INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 8 GLOBAL INJECTABLE DRUG DELIVERY BY USABILITY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 9 GLOBAL REUSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 10 GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 11 GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 12 GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 13 GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 14 GLOBAL DISPOSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 15 GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 16 GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 17 GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 18 GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 19 GLOBAL INJECTABLE DRUG DELIVERY BY TYPE MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 20 GLOBAL PHARMACEUTICAL DRUG FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 21 GLOBAL FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 22 GLOBAL CONVENTIONAL DRUGS DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 23 GLOBAL SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 24 GLOBAL RECONSTITUTED FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 25 GLOBAL SUSPENSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 26 GLOBAL EMULSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 27 GLOBAL ADVANCED DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 28 GLOBAL COLLOIDAL DISPERSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 29 GLOBAL LIPOSOMES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 30 GLOBAL NANOPARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 31 GLOBAL NOISOMES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 32 GLOBAL MICRO PARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 33 GLOBAL POLYMERIC MICELLES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 34 GLOBAL OTHER FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 35 GLOBAL INJECTABLE DRUG DELIVERY BY DEVICES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 36 GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 37 GLOBAL FILLABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 38 GLOBAL PRE FILLED INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 39 GLOBAL SELF-INJECTION DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 40 GLOBAL NEEDLE-FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 41 GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 42 GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 43 GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 44 GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 45 GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 46 GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 47 GLOBAL ANAEMIA MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 48 GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 49 GLOBAL HORMONAL INJECTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 50 GLOBAL RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 51 GLOBAL CROHN’S DISEASES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 52 GLOBAL MULTIPLE SCLEROSIS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 53 GLOBAL PSORIASIS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 54 GLOBAL REPRODUCTIVE HEALTH MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 55 GLOBAL ALLERGY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 56 GLOBAL OTHER THERAPEUTIC APPLICATION MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 1 GLOBAL INJECTABLE DRUG DELIVERY BY MODE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 2 GLOBAL ORAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 3 GLOBAL PULMONARY INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 4 GLOBAL TRANSDERMAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 5 GLOBAL NASAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 6 GLOBAL IMPLANTABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 7 GLOBAL OTHER INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 8 GLOBAL INJECTABLE DRUG DELIVERY BY USABILITY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 9 GLOBAL REUSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 10 GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 11 GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 12 GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 13 GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 14 GLOBAL DISPOSABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 15 GLOBAL SYRINGES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 16 GLOBAL NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 17 GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 18 GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 19 GLOBAL INJECTABLE DRUG DELIVERY BY TYPE MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 20 GLOBAL PHARMACEUTICAL DRUG FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 21 GLOBAL FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 22 GLOBAL CONVENTIONAL DRUGS DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 23 GLOBAL SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 24 GLOBAL RECONSTITUTED FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 25 GLOBAL SUSPENSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 26 GLOBAL EMULSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 27 GLOBAL ADVANCED DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 28 GLOBAL COLLOIDAL DISPERSIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 29 GLOBAL LIPOSOMES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 30 GLOBAL NANOPARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 31 GLOBAL NOISOMES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 32 GLOBAL MICRO PARTICLES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 33 GLOBAL POLYMERIC MICELLES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 34 GLOBAL OTHER FORMULATIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 35 GLOBAL INJECTABLE DRUG DELIVERY BY DEVICES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 36 GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 37 GLOBAL FILLABLE INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 38 GLOBAL PRE FILLED INJECTABLE DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 39 GLOBAL SELF-INJECTION DRUG DELIVERY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 40 GLOBAL NEEDLE-FREE INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 41 GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 42 GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 43 GLOBAL AUTO INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 44 GLOBAL FILLABLE MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 45 GLOBAL PRE FILLED MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 46 GLOBAL PEN INJECTORS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 47 GLOBAL ANAEMIA MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 48 GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 49 GLOBAL HORMONAL INJECTIONS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 50 GLOBAL RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 51 GLOBAL CROHN’S DISEASES MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 52 GLOBAL MULTIPLE SCLEROSIS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 53 GLOBAL PSORIASIS MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 54 GLOBAL REPRODUCTIVE HEALTH MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 55 GLOBAL ALLERGY MARKET RESEARCH AND ANALYSIS 2015-2021
TABLE # 56 GLOBAL OTHER THERAPEUTIC APPLICATION MARKET RESEARCH AND ANALYSIS 2015-2021
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
1. ALKERMES PLC
2. ANTARES PHARMA
3. BECTON DICKINSON AND COMPANY
4. BIOPHARMA SOLUTIONS (BAXTER INTERNATIONAL INC.)
5. ELI LILLY AND COMPANY
6. GENENTECH INC.
7. GERRESHEIMER AG
8. GLAXOSMITHKLINE INC.
9. HIKMA PHARMACEUTICALS PLC
10. LIFELONG MEDITECH LTD.
11. NOVARTIS
12. PFIZER INJECTABLES (PFIZER INC.)
13. SANDOZ
14. SCHOTT AG
15. SHL GROUP
16. TERUMO CORPORATION
17. TEVA PHARMACEUTICAL INDUSTRIES LTD
18. TROIKAA PHARMACEUTICALS LTD.
19. WEIGAO GROUP
20. YPSOMED
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
1. ALKERMES PLC
2. ANTARES PHARMA
3. BECTON DICKINSON AND COMPANY
4. BIOPHARMA SOLUTIONS (BAXTER INTERNATIONAL INC.)
5. ELI LILLY AND COMPANY
6. GENENTECH INC.
7. GERRESHEIMER AG
8. GLAXOSMITHKLINE INC.
9. HIKMA PHARMACEUTICALS PLC
10. LIFELONG MEDITECH LTD.
11. NOVARTIS
12. PFIZER INJECTABLES (PFIZER INC.)
13. SANDOZ
14. SCHOTT AG
15. SHL GROUP
16. TERUMO CORPORATION
17. TEVA PHARMACEUTICAL INDUSTRIES LTD
18. TROIKAA PHARMACEUTICALS LTD.
19. WEIGAO GROUP
20. YPSOMED
